| OncoKB: a precision oncology knowledge base D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ... JCO precision oncology 1, 1-16, 2017 | 2046 | 2017 |
| Organoid cultures derived from patients with advanced prostate cancer D Gao, I Vela, A Sboner, PJ Iaquinta, WR Karthaus, A Gopalan, ... Cell 159 (1), 176-187, 2014 | 1489 | 2014 |
| Covalent histone modifications—miswritten, misinterpreted and mis-erased in human cancers P Chi, CD Allis, GG Wang Nature reviews cancer 10 (7), 457-469, 2010 | 1296 | 2010 |
| PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors W Lee, S Teckie, T Wiesner, L Ran, CN Prieto Granada, M Lin, S Zhu, ... Nature genetics 46 (11), 1227-1232, 2014 | 546 | 2014 |
| Chromatin remodeling and cancer, Part I: Covalent histone modifications GG Wang, CD Allis, P Chi Trends in molecular medicine 13 (9), 363-372, 2007 | 535 | 2007 |
| Synapsin dispersion and reclustering during synaptic activity P Chi, P Greengard, TA Ryan Nature neuroscience 4 (12), 1187-1193, 2001 | 416 | 2001 |
| Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape C Lu, SU Jain, D Hoelper, D Bechet, RC Molden, L Ran, D Murphy, ... Science 352 (6287), 844-849, 2016 | 382 | 2016 |
| Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies P Chi, P Greengard, TA Ryan Neuron 38 (1), 69-78, 2003 | 355 | 2003 |
| ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours P Chi, Y Chen, L Zhang, X Guo, J Wongvipat, T Shamu, JA Fletcher, ... Nature 467 (7317), 849-853, 2010 | 345 | 2010 |
| Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial JY Blay, C Serrano, MC Heinrich, J Zalcberg, S Bauer, H Gelderblom, ... The Lancet Oncology 21 (7), 923-934, 2020 | 337 | 2020 |
| Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling GG Wang, CD Allis, P Chi Trends in molecular medicine 13 (9), 373-380, 2007 | 328 | 2007 |
| ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss Y Chen, P Chi, S Rockowitz, PJ Iaquinta, T Shamu, S Shukla, D Gao, ... Nature medicine 19 (8), 1023-1029, 2013 | 319 | 2013 |
| Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma AR Moore, E Ceraudo, JJ Sher, Y Guan, AN Shoushtari, MT Chang, ... Nature genetics 48 (6), 675-680, 2016 | 314 | 2016 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 312 | 2022 |
| Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: a phase 2 clinical trial MA Dickson, GK Schwartz, ML Keohan, SP D’Angelo, MM Gounder, P Chi, ... JAMA oncology 2 (7), 937-940, 2016 | 289 | 2016 |
| Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST CN Prieto-Granada, T Wiesner, JL Messina, AA Jungbluth, P Chi, ... The American journal of surgical pathology 40 (4), 479-489, 2016 | 247 | 2016 |
| Alternative transcription initiation leads to expression of a novel ALK isoform in cancer T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ... Nature 526 (7573), 453-457, 2015 | 241 | 2015 |
| Regulation of neurotransmitter release by synapsin III J Feng, P Chi, TA Blanpied, Y Xu, AM Magarinos, A Ferreira, ... Journal of Neuroscience 22 (11), 4372-4380, 2002 | 186 | 2002 |
| The management of metastatic GIST: current standard and investigational therapeutics CM Kelly, L Gutierrez Sainz, P Chi Journal of Hematology & Oncology 14 (1), 2, 2021 | 167 | 2021 |
| Roscovitine: a novel regulator of P/Q‐type calcium channels and transmitter release in central neurons Z Yan, P Chi, J A. Bibb, T A. Ryan, P Greengard The Journal of physiology 540 (3), 761-770, 2002 | 163 | 2002 |
